Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWDexmedetomidine-d3 is intended for use as an internal standard for the quantification of dexmedetomidine (Item No. 39544) by GC- or LC-MS. Dexmedetomidine is an agonist of α2-adrenergic receptors (α2-ARs).1 It selectively binds to α2-ARs over α1-ARs (Kis = 0.015 and 5 nM, respectively). In vivo, dexmedetomidine (50 µg/kg) prevents increases in cardiac troponin I (CTnI), a marker of myocardial injury, as well as reduces myocardial apoptosis, pyroptosis, and ferroptosis in a mouse model of sepsis induced by cecal ligation and puncture (CLP), effects that can be reversed by the α2-AR antagonist yohimbine (Item No. 19869).2 Dexmedetomidine (40 µg/kg) induces sedation and decreases mechanical nociception in cats.3 Formulations containing dexmedetomidine have been used as sedatives.
WARNING This product is not for human or veterinary use.
1. α2 Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-
2. Dexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury. Mol. Med. Rep. 22(1), 175-184 (2020).
3. Sedative effects of dexmedetomidine, dexmedetomidine-